FASENRA: payments to doctors
Payments that named FASENRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $29.6M
- Providers
- 34,024
- Transactions
- 259,962
- Average per transaction
- $114
The per-transaction average — $114 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 34,024 providers the average total is $869, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $28,401,127 | 96.1% |
| Astrazeneca UK Limited | $1,087,744 | 3.7% |
| Astrazeneca AB | $57,662 | 0.2% |
| Acerta Pharma LLC | $5,709 | 0.0% |